1. Home
  2. PRPO vs ULY Comparison

PRPO vs ULY Comparison

Compare PRPO & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • ULY
  • Stock Information
  • Founded
  • PRPO N/A
  • ULY 2013
  • Country
  • PRPO United States
  • ULY United States
  • Employees
  • PRPO N/A
  • ULY N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • ULY
  • Sector
  • PRPO Industrials
  • ULY
  • Exchange
  • PRPO Nasdaq
  • ULY Nasdaq
  • Market Cap
  • PRPO 9.9M
  • ULY 6.7M
  • IPO Year
  • PRPO N/A
  • ULY N/A
  • Fundamental
  • Price
  • PRPO $6.65
  • ULY $0.50
  • Analyst Decision
  • PRPO
  • ULY Strong Buy
  • Analyst Count
  • PRPO 0
  • ULY 1
  • Target Price
  • PRPO N/A
  • ULY $1.50
  • AVG Volume (30 Days)
  • PRPO 6.8K
  • ULY 82.0K
  • Earning Date
  • PRPO 03-28-2025
  • ULY 03-13-2025
  • Dividend Yield
  • PRPO N/A
  • ULY N/A
  • EPS Growth
  • PRPO N/A
  • ULY N/A
  • EPS
  • PRPO N/A
  • ULY 7.18
  • Revenue
  • PRPO $17,411,000.00
  • ULY $155,926,000.00
  • Revenue This Year
  • PRPO $75.18
  • ULY N/A
  • Revenue Next Year
  • PRPO N/A
  • ULY $4.29
  • P/E Ratio
  • PRPO N/A
  • ULY $0.07
  • Revenue Growth
  • PRPO 31.31
  • ULY N/A
  • 52 Week Low
  • PRPO $4.31
  • ULY $0.41
  • 52 Week High
  • PRPO $7.20
  • ULY $3.45
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 63.80
  • ULY 53.39
  • Support Level
  • PRPO $6.52
  • ULY $0.45
  • Resistance Level
  • PRPO $6.90
  • ULY $0.55
  • Average True Range (ATR)
  • PRPO 0.27
  • ULY 0.05
  • MACD
  • PRPO 0.03
  • ULY 0.01
  • Stochastic Oscillator
  • PRPO 89.90
  • ULY 76.92

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: